Covishield is `safe and immunogenic, has no side effects, asserts Serum Institute of India
The vaccine candidate, Covishield, is being developed by the UK's Oxford University and US pharma giant AstraZeneca. The SII is a manufacturing partner for the vaccine.
ليست هناك تعليقات:
إرسال تعليق